New Orthostatic Hypotension Treatment Reduces Symptoms Without Causing High Blood PressureTuesday, Apr 11, 2006
A drug traditionally used to treat myasthenia gravis shows potential benefit for reducing symptoms of orthostatic hypotension
without raising blood pressure when people lie down, according to results of a double-blind, controlled clinical trial.
NINDS Funds Five Specialized Neuroscience Programs at Minority InstitutionsTuesday, Jan 18, 2000
The National Institute of Neurological Disorders and Stroke (NINDS), in collaboration with the National Center for Research
Resources (NCRR) and the Office for Research on Minority Health (ORMH), recently awarded grants to five minority institutions
under a new funding mechanism called Specialized Neuroscience Research Programs at Minority Institutions (SNRP).
Audrey S. Penn, M.D., Named NINDS Deputy DirectorFriday, Mar 1, 1996
BETHESDA, MD - Audrey S. Penn, M.D., one of the nation's leading neurologists and a well-known scientist specializing in neuromuscular
disease research, has been named Deputy Director of the National Institute of Neurological Disorders and Stroke (NINDS).
Study Shows IVIG Safe, Effective Treatment for Muscle DiseaseWednesday, Dec 29, 1993
Patients with a painful and debilitating muscle disease called dermatomyositis showed dramatic improvement on a treatment
regimen of intravenous immune globulin (IVIG) during a recent double-blind, placebo-controlled trial. The study, which was
conducted at the National Institute of Neurological Disorders and Stroke (NINDS), will be published in the December 30 issue
of the New England Journal of Medicine.
Fact Sheet